Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
US Army
McKinsey
Farmers Insurance
Teva
Deloitte
Cipla
Johnson and Johnson
Moodys

Generated: October 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076250

« Back to Dashboard

NDA 076250 describes NIACIN, which is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Barr, Jubilant Generics, Lannett Co Inc, Lupin Ltd, Sun Pharma Global, Everylife, Halsey, Hikma Pharms, Impax Labs, Ivax Sub Teva Pharms, Mk Labs, Purepac Pharm, Sandoz, Tablicaps, Watson Labs, and Wockhardt, and is included in twenty-five NDAs. It is available from fifteen suppliers. Additional details are available on the NIACIN profile page.

The generic ingredient in NIACIN is niacin. There are fourteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the niacin profile page.
Summary for 076250
Tradename:NIACIN
Applicant:Barr
Ingredient:niacin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 076250
Ingredient-typeNicotinic Acids
Medical Subject Heading (MeSH) Categories for 076250
Suppliers and Packaging for NDA: 076250
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 076250 ANDA Teva Pharmaceuticals USA, Inc. 0093-7394 0093-7394-86 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-7394-86)
NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 076250 ANDA AvKARE, Inc. 42291-586 42291-586-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-586-90)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength1GM
Approval Date:Apr 14, 2005TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Chubb
Merck
Moodys
Healthtrust
Citi
Julphar
US Army
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.